Serum sickness–like reactions associated with cefprozil therapy - 07/10/17
Doi : 10.1016/S0022-3476(94)70220-9
Abstract |
Four patients had serum sickness–like reactions during treatment with cefprozil, a new cephalosporin. Two patients had had previous mild reactions associated with cephalosporin therapy. It remains uncertain whether ceprozil-associated serum sickness–like reaction represents a unique or a class-related adverse drug reaction. (J PEDIATR 1994;125:325-8)
Le texte complet de cet article est disponible en PDF.Abbreviations : EM, SJS, SSLR
Plan
 | From the Divisions of Pediatric Clinical Pharmacology, Allergy and Immunology, and Infectious Disease, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock; the Arkansas Children's Hospital Research Institute; and the Departments of Nursing Service and Pharmacy, Arkansas Children's Hospital, Little Rock |
| Reprint requests: Gregory L. Kearns, PharmD, Chief, Division of Pediatric Clinical Pharmacology, Department of Pediatrics, Arkansas Children's Hospital, 800 Marshall St., Little Rock, AR 72202. |
 | 0022-3476/94/$3.00 + 0 9/26/55820 |
© 1994
Mosby, Inc. Tous droits réservés.
Vol 125 - N° 2
P. 325-328 - août 1994 Retour au numéro
Article précédent
- Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure
- Scott A. Rivkees, Marco Danon, John Herrin
- Hyperglycemia during replacement growth hormone therapy
- Anil Kumar Garg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?